BiotechTube
MedLark

MedLark

San Francisco, United States· Est.
medlarkconsulting.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $1.5M

Overview

MedLark Consulting is a private, US-based services firm focused on the digital health sector, specifically regulatory and quality compliance for medical devices and biotech. The company generates revenue by providing consulting services including QMS development, audit preparation, regulatory submissions, and strategic advisory, positioning itself as a practical alternative to large consulting firms. Led by founder and CEO Resham Ramsay, MedLark emphasizes a tailored, experience-driven approach to help clients navigate complex regulatory landscapes and reduce compliance risk. Its target market benefits from increasing global regulatory scrutiny and the proliferation of new medical technologies requiring specialized compliance expertise.

Digital Health

Technology Platform

The company does not have a technology platform in the product sense. Its core offering is regulatory and quality compliance consulting expertise, methodologies, and strategic frameworks applied to medical device and biotech client needs.

Funding History

1
Total raised:$1.5M
Seed$1.5M

Opportunities

Growing regulatory complexity (e.g., EU MDR, SaMD guidelines) and an expanding global medtech startup ecosystem create sustained demand for specialized compliance services.
The company's boutique, senior-expert model is well-positioned to capture clients dissatisfied with the high-cost, impersonal approach of large consulting firms.

Risk Factors

High dependency on founder reputation and key personnel poses a significant key-person risk.
The business is also exposed to economic and funding cycles in the biotech/medtech sector, as downturns can lead clients to reduce discretionary consulting spend.
Competition from both independent consultants and larger firms is persistent.

Competitive Landscape

MedLark competes in a fragmented regulatory consulting market against solo practitioners, boutique firms, and large global consultancies (e.g., Parexel, IQVIA's consulting arms). Its differentiation is offering senior-level, practical expertise with a tailored approach, positioning itself between generic large-firm templates and potentially less experienced independents.

More companies in United States →